Stay updated on BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page
- Check5 days agoChange DetectedA general notice about changes to NIH website terminology appears above the ClinicalTrials.gov error page, and the site revision label is updated.SummaryDifference1%

- Check12 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check32 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the previous content with a minimal error screen and a Home link. This indicates the page is currently inaccessible due to access restrictions or a server issue.SummaryDifference18%

- Check39 days agoChange DetectedThe page shows a new revision tag (v3.7.0) replacing the previous v3.6.6, signaling an updated version of the page content.SummaryDifference0.0%

- Check53 days agoChange DetectedA new page revision, v3.6.6, has been posted, replacing the previous v3.6.5. This appears to be a minor site update rather than a modification to study data or participant information.SummaryDifference0.0%

- Check60 days agoChange DetectedThe study record now includes an NIH funding line indicating support from a U.S. NIH grant/contract in 2018, adding funding context to the study documentation. This clarifies the source of support for the trial within the record.SummaryDifference0.0%

Stay in the know with updates to BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.